Anti-cancer
Capecitabine
CAS No.
154361-50-9
An orally administered fluoropyrimidine carbamate prodrug of 5-fluorouracil, used in oncology formulations for colorectal and breast cancers.
Capecitabine is an oral fluoropyrimidine prodrug API manufactured by NovaAcura Biotech under stringent GMP quality systems appropriate to oncology API handling. Full batch documentation and regulatory support are available for global oncology formulation partners.
Applications & Uses
An orally administered fluoropyrimidine carbamate prodrug of 5-fluorouracil, used in oncology formulations for colorectal and breast cancers.
Full technical documentation, batch specifications and regulatory support (DMF/CEP) are available on request.
Need This Molecule at Scale?
Get in touch for pricing, lead times and full regulatory documentation.
Get In Touch